Marshall Wace
DXCM icon

Marshall Wace’s DexCom DXCM Stock Holding History

Marshall Wace’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
1,700
+700
+70% +$48.7K ﹤0.01% 2888
2025
Q4 		$66.4K Buy
+1,000
New +$64.7K ﹤0.01% 2753

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marshall Wace's DXCM Position: Q1 2026 in Review

Marshall Wace reduced its DexCom (DXCM) stake by 64% in Q1 2026, selling an estimated $8.63M and leaving 68,214 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Marshall Wace first reported a position in DXCM in Q4 2014 and has held it in 27 quarters since. The position peaked at $343M in Q1 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Marshall Wace held 68,214 shares of DexCom worth $4.28M as of Q1 2026.
  • Marshall Wace sold 123,865 DexCom shares in Q1 2026, an estimated $8.63M.
  • DexCom made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1378 holding.
  • Marshall Wace first reported a position in DexCom in Q4 2014 and has held it in 27 quarters since.
  • Marshall Wace's DexCom position peaked at $343M in Q1 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.